We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.12B
AUM Growth
–
Cap. Flow
+$1.66B
Cap. Flow %
78.16%
Top 10 Hldgs %
29.11%
Holding
114
New
97
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$77.5M
2
INFI
Infinity Pharmaceuticals, Inc.
INFI
+$72.9M
3
ARRY
Array Biopharma Inc
ARRY
+$58.5M
4
PFE icon
Pfizer
PFE
+$54M
5
NXTM
NxStage Medical Inc.
NXTM
+$49.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 50.73%
2 Technology 1.58%
3 Financials 1.05%
4 Energy 0.02%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WINT
76
DELISTED
Windtree Therapeutics Inc
WINT
$2.03M 0.1%
+95,214
New +$2.35M
RAD
77
DELISTED
Rite Aid Corporation
RAD
$2M 0.09%
+35,000
New +$1.83M
GILD icon
78
Gilead Sciences
GILD
$167B
$1.79M 0.08%
+35,000
New +$1.82M
SVRA icon
79
Savara
SVRA
$1.13B
$1.7M 0.08%
+56,404
New +$2.5M
CTRX
80
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
$1.46M 0.07%
+30,000
New +$1.56M
PTN
81
Palatin Technologies
PTN
$16.2M
$1.24M 0.06%
+1,600
New +$1.23M
IRWD icon
82
PUT
Ironwood Pharmaceuticals
IRWD
$635M
$993K 0.05%
+119,400
New +$1.45M
XTNT icon
83
Xtant Medical Holdings
XTNT
$63.1M
$866K 0.04%
+16,037
New +$1.33M
GTIV
84
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$775K 0.04%
+77,839
New +$808K
SLTM
85
DELISTED
SOLTA MED INC (DE)
SLTM
$773K 0.04%
+339,063
New +$715K
WCRX
86
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$688K 0.03%
+34,543
New +$585K
HOLX
87
DELISTED
Hologic
HOLX
$676K 0.03%
+35,000
New +$731K
ILMN icon
88
Illumina
ILMN
$28.2B
$629K 0.03%
+8,634
New +$553K
MYGN icon
89
Myriad Genetics
MYGN
$584M
$505K 0.02%
+18,777
New +$544K
QCOR
90
DELISTED
QUESTCOR PHARMA INC
QCOR
$454K 0.02%
+10,000
New +$355K
LHCG
91
DELISTED
LHC Group LLC
LHCG
$374K 0.02%
+19,087
New +$421K
ECYT
92
DELISTED
Endocyte, Inc. Common Stock
ECYT
$364K 0.02%
+27,708
New +$374K
ALKS icon
93
Alkermes
ALKS
$8.79B
$315K 0.01%
+11,000
New +$321K
AFAM
94
DELISTED
Almost Family Inc
AFAM
$252K 0.01%
+13,200
New +$261K
SPPI
95
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$237K 0.01%
+31,750
New +$244K
ICAD
96
DELISTED
iCAD Inc
ICAD
$233K 0.01%
+38,887
New +$214K
OREX
97
DELISTED
Orexigen Therapeutics, Inc.
OREX
$132K 0.01%
+2,258
New +$139K
1 2 3
4

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $8.5B AUM 25.14% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return

Deerfield Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Deerfield Management, which disclosed 114 positions worth $2.12B. Its ten largest holdings account for 29% of the portfolio.

Its largest position is AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Technology and Financials.

  • Deerfield Management's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.
  • Deerfield Management's ten largest holdings make up 29% of its $2.12B portfolio in Q2 2013.
  • Deerfield Management disclosed 114 positions in Q2 2013, its first 13F filing on record.

Based on Deerfield Management's 13F filing for Q2 2013, filed 14 Aug 2013.